Contact this trialFirst, we need to learn more about you.
Polyamine Synthesis Inhibitor
DFMO for Type 1 Diabetes
Recruiting0 awardsPhase 2
Chicago, Illinois
This trial tests if a drug, DFMO, helps reduce stress on cells that make insulin and preserves insulin production in people with Type 1 Diabetes. Participants take DFMO/placebo 2x/day for 6 months & have 6 in-person & 1 phone visit over 12 months.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.